A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD. Wehkamp L, Harris DMM, Kim NM, Alsaadi AI, et al. J Crohns Colitis 2026;20:jjag043.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wehkamp L, Harris DMM, Kim NM, Alsaadi AI, et al. A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD. J Crohns Colitis 2026;20:jjag043.
PMID: 42223054